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background: Coronary artery disease (CAD) is present in 40-50% of patients admitted with acute decompensated heart failure (ADHF). 
However - due to its uncertain and unproven benefit - coronary angiography (CAG) is performed only in 10% of ADHF admissions. 
Troponin T elevation as a marker for ischemia may be of use to select more patients for CAG. Our aim was to investigate the effect of CAG 
during admission on 180-day mortality and morbidity.
methods: Consecutive patients admitted to our hospital for ADHF in 2009-2012 were entered in a dedicated database. Primary endpoint 
was a composite of all-cause mortality and cardiovascular readmission from admission to 180 days after discharge. Cut-off levels 
for elevated troponin T were adopted from international guidelines for diagnosis of ACS. The effect of CAG on primary endpoint was 
investigated separately in patients with (TnT+) and without troponin T elevation (TnT-), using Cox regression analysis. Then, propensity-
matched analysis was performed in TnT+ patients to examine whether CAG was independently associated with the composite endpoint 
(CAG+ 37 patients vs. CAG- 50 patients).
results: A number of 493 consecutive ADHF patients (53% male, age 75 (IQR 64-83)) were followed for a median of 604 days (IQR 173-
1081). Troponin T was elevated in 164 patients (46%). In TnT- and TnT+ patients, a CAG was performed in 14% and 30% respectively 
(p<0.001). In the TnT- group, hazard ratio (HR) for patients in whom a CAG was performed was 1.04 (0.5-2.0, p=0.9), in TnT+ patients 0.46 
(0.3-0.8, p=0.003). In propensity matched analysis, a significant difference was observed for the combined endpoint between TnT+ patients 
without and with CAG (respectively 62% vs. 42%, p = 0.03). Univariate Cox regression analysis demonstrated an HR of 0.5 (95% CI; 0.3-
0.95, p = 0.037) for performance of CAG on the combined endpoint in TnT+ patients.
Conclusion:  In ADHF patients with elevated troponin T levels, mortality and readmission rates were significantly lower when CAG was 
performed. Prospective studies are urgently needed.
